ROS and superoxide decrease in the dormant form of mycobacteria. by Amar Yeware (7115063)

Decrease of total symptom score during the study by R Lozano (33248)

IGF-1 injections significantly attenuate the increase in macrophages and neutrophils observed at day 30 following IR. by Jordan A. Gunning (18143970)

IGF-1 injections significantly attenuate the increase in CD4+CD8+ double positive T cells seen at day 30 after IR. by Jordan A. Gunning (18143970)

Depletion of EphA3 or EphA4 recovers the decreased ERK and Akt activation and lytic gene expression in RNF5 KO PEL cells. by Xiaojuan Li (351842)

TG6-44 treatment leads to decrease in A/X31-induced cell death in PBMC. by Juan A. De La Cruz (11154187)

Decrease in CLPs, NKPS and Block in NKP progression. by John Richards (53768)

Brain surgeries transiently decrease the singing rate. by Homare Yamahachi (363988)

Decrease of ERK phosphorylation by NOS inhibitor TRIM. by Immacolata Castellano (603814)

Multiple miRNAs decrease telomerase activity. by Radmila Hrdličková (523455)

Knockdown of p65 in A549 cells results in a decreased infection rate. by Janine J. Wilden (8849948)

BA decreases DUB activity in PC cells. by Teresita Reiner (281437)

“…(<b>B</b>) DUB assay showed that BA treatment of LNCaP cells significantly decreased DUB activity at 24 and 48 h relative to control treated cells ( = 1) (*, <i>P</i><5×10⁻⁵). …”

Decreased expression of CXCR5 on SHIV-specific CD8+ T cells and NK cells after N-803 in lymph nodes. by Gabriela M. Webb (8566788)

Complex I inhibitor decreases ROS level by Zheng Li (26302)

Decreased neutrophils in <i>MiR125a</i>^<i>-/-</i> mice. by Yuting Qin (1950118)

GSH content was decreased in low glucose conditions. by Martine Emery (215947)

Increased osmolarity decreases the activity of the cytochrome pathways. by Wilson Garcia-Neto (3622400)

VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

“…The median rank of overexpression is shown by the spectrum of white-pink-red colors shown in the legend; VRK1 is in the top 5% of overexpressed mRNAs in subsets 2,3,6–9 and in the top 10% of overexpressed mRNAs in subsets 5 and 11. …”

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Comparison of estimated arterial cerebral blood volumes (aCBVs) (Mean ± SD^*) between multiphase bSSFP and AVAST (N = 5). by Ki Hwan Kim (427869)